The product has not yet been released on the market.
Description
Rivaroxaban-Tchaikapharma contains the active substance rivaroxaban and o belongs to a group of medicines called antithrombotic agents. It works by blocking a blood clotting factor (factor Xa) and thus reducing the tendency of the blood to form clots.
Indications
Rivaroxaban-Tchaikapharma is indicated for:
- prevent blood clots in the veins after a hip or knee replacement operation. Your doctor has prescribed this medicine for you because after an operation you are at an increased risk of getting blood clots.;
- treat blood clots in the veins of your legs (deep vein thrombosis) and in the blood vessels of your lungs (pulmonary embolism), and to prevent blood clots from re-occurring in the blood vessels of your legs and/or lungs.
Subject to medical prescription.
Concentration and pharmaceutical form: 10 mg, 15 mg, 20 mg film-coated tablets